MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$10K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Due to related party
Depreciation and amortization
Accounts payable
Others
Negative Cash Flow Breakdown
Net loss from operations
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss from operations
-699
-2,284
5,235
-17,105
Depreciation and amortization
284
285
286
288
Stock based compensation
0
1,440
8
1
Issuance of shares for professional services rendered
-
-
0
0
Accrued interest on notes payable
-
-
0
262
Change in deferred tax liability
-
-
-2,580
-
Change in fair value of note payable, related party
-
-
-3,822
268
Impairment of inventory
-
-
419
-
Loss on disposal of fixed assets
-
-
-12
-
Accounts receivable
0
-5
-10
15
Inventory
-1
-
-3
-1
Prepaid expenses and other current assets
-44
-47
-63
35
Accounts payable
93
27
607
22
Accrued expenses
38
16
-142
69
Due to related party
709
-
-
-
Net cash provided (used) by operating activities
470
-464
99
-613
Borrowings on notes receivable
-
1
-
-
Payments received on notes receivable
1
-
1
1
Net cash provided by investing activities
2
-1
1
1
Borrowings from related party
-
482
184
-
Payments to related party
-
-
293
-
Net provided by financing activities
-
482
-109
-
Net increase (decrease) in cash
-10
17
-9
-612
Cash at beginning of period
20
3
12
1,999
Cash at end of period
10
20
3
12
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Due to related party
$709K
Payments received on
notes receivable
$1K
(0.00%↑ Y/Y)
something is missing
$1K
Depreciation and
amortization
$284K
(-50.26%↓ Y/Y)
Accounts payable
$93K
(158.49%↑ Y/Y)
Prepaid expenses and
other current assets
-$44K
(55.10%↑ Y/Y)
Accrued expenses
$38K
(-46.48%↓ Y/Y)
Inventory
-$1K
(66.67%↑ Y/Y)
Net cash provided
(used) by operating...
$470K
(134.16%↑ Y/Y)
Net cash provided by
investing activities
$2K
(100.00%↑ Y/Y)
Canceled cashflow
$699K
Net increase
(decrease) in cash
-$10K
(99.27%↑ Y/Y)
Canceled cashflow
$472K
Net loss from
operations
-$699K
something is missing
-$482K
Buy us a coffee
IMPACT BIOMEDICAL INC. (IBO)
IMPACT BIOMEDICAL INC. (IBO)